Aastrom's adult stem cell tech shows promise in US bone fracture trial
This article was originally published in Clinica
Executive Summary
The use of Aastrom Biosciences' adult stem cell-based technology as a treatment for non-union long bone fractures appears to be safe and effective, according to early results from an ongoing phase II US trial.